Welcome to LookChem.com Sign In|Join Free

CAS

  • or

935273-86-2

935273-86-2

Post Buying Request

935273-86-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

935273-86-2 Usage

Uses

Benzyl 3,3-difluorocyclobutanecarboxylate are carboxylic acid ester derivatives and can be used as pharmaceutical intermediates.

Check Digit Verification of cas no

The CAS Registry Mumber 935273-86-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,5,2,7 and 3 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 935273-86:
(8*9)+(7*3)+(6*5)+(5*2)+(4*7)+(3*3)+(2*8)+(1*6)=192
192 % 10 = 2
So 935273-86-2 is a valid CAS Registry Number.

935273-86-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name benzyl 3,3-difluorocyclobutane-1-carboxylate

1.2 Other means of identification

Product number -
Other names 3,3-Difluorocyclobutanecarboxylic acid phenylmethyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:935273-86-2 SDS

935273-86-2Relevant articles and documents

JAK INHIBITORS

-

, (2018/05/03)

Disclosed is a series of JAK inhibitors, which specifically relates to a compound shown in formula (I) or pharmaceutically acceptable salts thereof.

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

-

, (2015/02/19)

Provided are methods of treating a cancer characterized by the presence of a mutant allele of IDH1/2 comprising administering to a subject in need thereof a compound described here.

THERAPEUTICALLY ACTIVE COMPOUNDS AND USE THEREOF

-

, (2015/02/19)

Provided are therapeutically active compounds and the use in manufacture of medicaments for treating a cancer characterized by the presence of a mutant allele of IDH1.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 935273-86-2